Overview of Roseola Infantum

Roseola infantum, also called exanthem subitum or three-day fever, is a common viral infection in infants and toddlers caused by human herpesvirus 6 (HHV-6). The condition typically affects children between 6 months and 2 years of age and is characterized by an unusual symptom pattern: high fever lasting 3-5 days followed by the appearance of a rose-pink maculopapular rash after defervescence. This distinctive sequence of fever followed by rash—with the rash appearing as fever resolves—differentiates roseola from other childhood exanthems. While roseola is generally self-limited and benign, the high fever associated with the initial infection can trigger febrile seizures in susceptible infants, representing a notable complication. The disease is very common, with most children acquiring HHV-6 infection by age 3.

Epidemiology and Viral Characteristics

Roseola infantum is caused by human herpesvirus 6 (HHV-6), a member of the Herpesviridae family. Two variants, HHV-6A and HHV-6B, have been identified, with HHV-6B being the primary cause of typical roseola infantum in infants and young children. HHV-6A is associated with a broader range of age groups and disease presentations. Transmission occurs through respiratory secretions, and most children acquire infection by age 3, making HHV-6 a ubiquitous virus. Roseola occurs year-round without marked seasonal variation in most geographic regions, though some reports suggest slight increases in spring and fall. The virus primarily infects infants at the age when maternal antibodies wane but before adaptive immune responses have fully developed. Infected individuals may shed virus in saliva for weeks to months after primary infection, though clinical illness resolves earlier.

Clinical Presentation and Course

Roseola typically begins with an abrupt onset of high fever, often reaching 39-41°C (102-105°F), without clear source. The fever is distinctive in that it rises quickly and persists for 3-5 days despite treatment with antipyretics. Notably, during this high-fever phase, the child characteristically appears relatively well, without significant respiratory symptoms, sore throat, or gastrointestinal complaints—a presentation sometimes described as "fever without source" or "high fever with minimal systemic toxicity." Accompanying symptoms may include irritability, lethargy, reduced appetite, mild diarrhea, and occasionally cough. Febrile seizures occur in 10-15% of affected infants, a notable complication related to the height and rapidity of fever rise rather than any neurotoxic viral effect. As the fever abruptly resolves—sometimes within hours—a characteristic rash appears on the trunk and neck, typically sparing the face. The rash consists of discrete, pale rose-pink macules and maculopapules, nonpruritic, blanching with pressure, and typically lasting 1-2 days. Once the rash appears, the child typically recovers completely.

Complications and Associated Risks

While roseola infantum is generally benign, febrile seizures represent a significant complication occurring in 10-15% of affected infants. These generalized seizures result from the rapid temperature rise rather than specific neurotoxicity from HHV-6. The seizures are typically brief (seconds to minutes), generalized, and self-limited. Although alarming for parents, febrile seizures associated with roseola carry the same generally benign prognosis as febrile seizures from other causes. Status epilepticus is rare. Rare complications include hepatitis with elevated liver enzymes, meningitis, encephalitis, and hemophagocytic syndrome, though these occur predominantly in immunocompromised patients. Secondary bacterial infection of the rash does not typically occur, as the rash is transient and superficial. In immunocompromised patients, HHV-6 can cause severe disease with dissemination and serious complications. Encephalitis has been reported, particularly in young infants, though remains rare in immunocompetent children. Most children recover completely without sequelae.

Diagnosis and Laboratory Findings

Diagnosis is primarily clinical based on the distinctive fever pattern followed by rash. The characteristic presentation of 3-5 days of high fever, relative clinical well-being despite fever severity, followed by appearance of pink maculopapular rash on trunk after defervescence is pathognomonic for roseola infantum. Laboratory testing is typically unnecessary in classic presentations. When confirmation is desired, serology showing HHV-6-specific IgM antibodies indicates acute infection, while IgG antibodies indicate past exposure and immunity. PCR testing detecting HHV-6 DNA in saliva or blood can confirm diagnosis but is not routinely performed. During the fever phase, laboratory investigation may be pursued to exclude other serious causes of high fever, including CBC, blood cultures, and urinalysis if bacterial infection is suspected. However, the resolution of fever with appearance of rash typically confirms the diagnosis retrospectively. The rash itself is not usually biopsied or cultured, as the diagnosis is established clinically.

Management and Treatment

Management of roseola infantum is supportive, as no specific antiviral therapy is indicated for immunocompetent infants. Treatment focuses on fever management with antipyretics including acetaminophen and ibuprofen, adequate hydration, and supportive care. Tepid bathing may provide comfort, though cooling measures should be used cautiously to avoid excessive drops in temperature. Parents should be reassured about the excellent prognosis despite the high fever and appearance of rash. In infants at high risk for febrile seizures, appropriate seizure precautions and family education about seizure management are important. Antiviral therapy with acyclovir or ganciclovir is not routinely recommended for immunocompetent patients but may be considered in immunocompromised hosts with severe disease. Once the rash appears, contagiousness decreases significantly, and children may return to regular activities as they feel well. Most children recover completely within 2-7 days.

Frequently Asked Questions

Why does the fever occur before the rash? The fever represents the acute viremic phase of HHV-6 infection, while the rash appears as the immune response develops and viremia clears, hence appearing after fever resolves.

Should I be concerned about the high fever? The high fever is typical for roseola and should be managed with antipyretics, fluids, and observation. Febrile seizures can occur but carry the same generally benign prognosis as with other viral infections.

Will the rash leave scars? No. Roseola rashes are superficial and transient, resolving within 1-2 days without scarring or permanent skin changes.

How long is my child contagious? Infectivity is highest during the fever phase but decreases as the rash appears and fever resolves. Virus can shed in saliva for weeks afterward.

Does my child need antibiotics? No. Roseola is a viral infection and does not require antibiotic therapy. Recovery is spontaneous and complete.

References

  1. Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology. 5th ed. Elsevier; 2016.
  2. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1(8594):1065-1067.
  3. Carrillo-Bustamante P, Kekarainen T, Sacirbegovic F, et al. How viruses hijack the immune system: pathogenic strategies and implications for vaccine development. J Immunol. 2014;193(6):2651-2661.
  4. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol. 2005;32(3):183-193.
  5. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Elsevier; 2016.
  6. Landry ML. Diagnostic procedures for viral infections. Clin Infect Dis. 2011;53(2):128-136.
  7. Broccolo F, Drago F, Caredda F, et al. HHV-6 variants in children with exanthem subitum and other febrile conditions. Eur J Pediatr. 2000;159(8):633-637.
  8. Asano Y, Yoshikawa T, Suga S, et al. Clinical features and viral characteristics of exanthem subitum. J Clin Virol. 1998;10(2):131-137.